Metal-on-Metal Hip Replacement Failures Result in Ban at UK NHS Hospitals

Amid continuing concerns about the risk of problems with metal-on-metal hip replacements, which have been linked to high failure rates and a potentially “toxic” impact on the body, the United Kingdom has banned use of the controversial hip implant design at all hospitals funded by the National Health Service (NHS).  

The National Institute for Health and Care Excellence (NICE) in the U.K. issued a draft guidance earlier this month, which requires all hip replacement systems have a 5% or less failure rate over 10 years.

The requirement excludes all metal-on-metal hip implants, because none of them have a success rate that high. The guidance came shortly after a report indicated that the DePuy ASR metal-on-metal hip systems had a failure rate of more than 40% over 10 years.

Learn More About

DePuy ASR Hip Lawsuits

Lawsuits are being reviewed for several different dangerous and defective hip replacement systems.

Learn More About this Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

Virtually all hospitals in England would be required to stop using metal-on-metal hip replacement systems of any kind due to the ruling. The country has a publicly funded health system that requires all of the NHS hospitals to abide by the guidance.

Previously, NICE guidance allowed a failure rate as high as 10%, which would still have excluded many metal-on-metal hip implant designs. However, officials said that the new rate came following information on how long artificial hips can and should last.

Concerns have surfaced in recent years about potentially “toxic” side effects of metal-on-metal hip replacements, due to the release of metallic debris as the parts rub against each other, a condition known as metallosis. In large numbers of patients who received the implants, these problems may cause the hip replacements to loosen or fail catastrophically, often resulting in the need for revision surgery.

In the United States, the FDA released new guidance for metal-on-metal hip replacements early this year, advising doctors that metal-on-metal hip implants should only be used if other artificial hip replacements were not appropriate.

Information from a British joint registry first highlighted the risk of problems with DePuy ASR hip replacements, indicating in 2010 that users were experiencing a failure rates of 12 to 13% after only just a few years. These findings resulted in a worldwide DePuy ASR metal-on-metal hip recall in August 2010.

Thousands of former patients in the U.S. are now pursuing DePuy ASR lawsuits against Johnson & Johnson and their DePuy Orthopaedics subsidiary. At least two cases have already gone to trial, with one case in California resulting in an $8.3 million damage award and a second case in Illinois state court resulting in a defense verdict.

In addition, a number of product liability lawsuits have been filed over other metal-on-metal hip systems, which feature similar designs, including the DePuy Pinnacle hip implantsBiomet M2A Magnum metal hips and Wright Medical Conserve Cup.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Fairness of Philips CPAP Recall Settlement Being Evaluated By MDL Judge
Fairness of Philips CPAP Recall Settlement Being Evaluated By MDL Judge (Posted yesterday)

A federal judge has held a fairness hearing for a proposed Philips CPAP class action lawsuit settlement, which seeks to resolve claims that consumers suffered economic damages due to the massive recall over toxic sound abatement foam.